Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Principal, EcoR1 Capital
Caroline Stout is a Principal at EcoR1 Capital, a biotechnology focused investment fund in San Francisco. She focuses on investments in private and public therapeutics companies, across indications and stages of development. She serves as a board member to Prevail Therapeutics and Accent Therapeutics. Prior to joining EcoR1 Capital, Caroline worked in New York as an investment banker at Credit Suisse. Caroline graduated magna cum laude from Georgetown University with a bachelor’s degree in Economics, a pre-medical concentration, and a minor in Cognitive Science.